Privacy Analytics has announced it is teaming with CancerLinQ in an effort to de-identify cancer patient data on a large scale for research purposes, stressing that adhering to privacy regulation will be paramount. “Privacy Analytics is providing CancerLinQ with software and training that will allow CancerLinQ to responsibly de-identify patient data through a proven, risk-based methodology,” the firm’s announcement states. This will allow CancerLinQ to provide oncologists with reports “that can be customized for each specific use case and objective while protecting patient privacy.” Healthcare providers will now have access to “critical patient data from electronic health records that they would not have historically been able to access and analyze through traditional methods,” said Privacy Analytics CEO Khaled El Emam.
Full Story